Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat model.

The profile of a series of triazine and pyrimidine based ROCK inhibitors is described. An initial binding mode was established based on a homology model and the proposed interactions are consistent with the observed SAR. Compounds from the series are potent in a cell migration assay and possess a favorable kinase selectivity. In vivo activity was demonstrated for compound 1A in a spontaneous hypertensive rat model.

[1]  Christopher G Sobey,et al.  Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. , 2006, Trends in pharmacological sciences.

[2]  Helmut Mack,et al.  Rho kinase, a promising drug target for neurological disorders , 2005, Nature Reviews Drug Discovery.

[3]  S. Semus,et al.  Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors. , 2007, Journal of medicinal chemistry.

[4]  J. Stasch,et al.  Design and Synthesis of Potent and Selective Azaindole‐Based Rho Kinase (ROCK) Inhibitors , 2008, ChemMedChem.

[5]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[6]  J. Sportsman,et al.  Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening. , 2004, Assay and drug development technologies.

[7]  H. Saito,et al.  Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation , 2002, Journal of leukocyte biology.

[8]  R. Huber,et al.  Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity. , 2003, Structure.

[9]  S. Semus,et al.  Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity. , 2007, Journal of medicinal chemistry.

[10]  M. Fleming,et al.  The Structure of Dimeric ROCK I Reveals the Mechanism for Ligand Selectivity* , 2006, Journal of Biological Chemistry.

[11]  Dexter L. Lee,et al.  Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. , 2004, Hypertension.

[12]  Alex M. Clark,et al.  2D Structure Depiction , 2006, J. Chem. Inf. Model..

[13]  K. Kaibuchi,et al.  Adenovirus-Mediated Transfer of Dominant-Negative Rho-Kinase Induces a Regression of Coronary Arteriosclerosis in Pigs In Vivo , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[15]  A. Takeshita,et al.  Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. , 2001, Cardiovascular research.